US 8383099
Adoptive cell therapy with young T cells
granted A61KA61K2039/515A61K2239/31
Quick answer
US patent 8383099 (Adoptive cell therapy with young T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/515, A61K2239/31, A61K2239/38, A61K2239/57